Class II HLA interactions modulate genetic risk for multiple sclerosis

Keywords

Affiliated Institutions

• Harvard University US
• Assistance Publique – Hôpitaux de Paris FR
• The University of Melbourne AU
• Copenhagen University Hospital DK
• Yale University US
• Medical Research Council GB
• Helmholtz Zentrum München DE
• Universität Hamburg DE
• John Radcliffe Hospital GB
• Università degli Studi del Piemonte Orientale “Amedeo Avogadro” IT
• Broad Institute US
• University of Oslo
• Technical University of Munich DE
• Karolinska Institutet SE
• Munich Cluster for Systems Neurology DE
• Harvard NeuroDiscovery Center US
• Centre National de la Recherche Scientifique FR
• Institute for Integrative and Experimental Genomics DE
• Centre for Human Genetics GB
• Institute for Molecular Medicine Finland FI
• Deleted Institution
• Competence Network Multiple Sclerosis DE
• University of Helsinki FI
• The University of Sydney AU
• MRC Human Immunology Unit GB
• Brigham and Women's Hospital US
• KU Leuven BE
• University of Cambridge GB
• Royal Children's Hospital AU
• University Medical Center Hamburg-Eppendorf DE
• Danish Multiple Sclerosis Center DK
• Finland University FI
• Westmead Institute AU
• University of Oxford GB
• University of Miami US
• Oslo University Hospital
• Inserm FR
• Center for Human Genetics US
• University Medical Center of the Johannes Gutenberg University Mainz DE
• Stanford University US
• University of Lübeck DE
• Johannes Gutenberg University Mainz DE
• Wellcome Sanger Institute GB
• Murdoch Children's Research Institute AU
• Institut du Cerveau FR
• University of California, San Francisco US
• Vanderbilt University Medical Center US
• University of Tasmania AU
• Klinikum rechts der Isar DE

Related Publications